KPI Therapeutics
Developing first in class autoimmune drugs to meet unmet medical needs.
Launch date
Employees
Seattle Washington (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Series A | ||
| N/A | $30.0k | Debt | |
N/A | Debt | ||
| N/A | $50.5k | Debt | |
| Total Funding | - | ||
Related Content
Recent News about KPI Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.